Search results for "chronic"

showing 10 items of 3309 documents

Direct-acting antivirals for hepatitis C virus infections in patients co-infected with human immunodeficiency virus

2011

Summary Nearly three-quarters of human immunodeficiency virus–hepatitis C virus (HIV-HCV) coinfected patients in France currently need to be cured of their chronic HCV infection. The increase in sustained virological response rates obtained with the recently available HCV protease inhibitors in treatment-naive genotype-1 patients has generated considerable hope in these co-infected patients. However, several particularities (such as a higher baseline HCV load, more advanced liver fibrosis, frequent co-morbidities, and the risk of toxicity and drug–drug interactions) have not allowed the direct extrapolation of the results observed in HCV-monoinfected patients to patients with HIV-HCV co-inf…

medicine.medical_specialtyHepatitis C virusHuman immunodeficiency virus (HIV)HIV InfectionsContext (language use)medicine.disease_causeAntiviral AgentsViruschemistry.chemical_compoundPegylated interferonFibrosismedicineHumansIntensive care medicineHepatologybusiness.industryRibavirinGastroenterologyvirus diseasesHepatitis C Chronicmedicine.diseasechemistryImmunologyToxicitybusinessAlgorithmsmedicine.drugClinics and Research in Hepatology and Gastroenterology
researchProduct

Direct-acting antiviral-based therapy for chronic hepatitis C virus in HIV-infected patients

2015

The aim of this review was to detail the current therapies and treatments for chronic hepatitis C virus in coinfected patients, focusing on HCV antiviral agents currently used in practice today or scheduled to enter the open market soon. Several direct-acting antiviral (DAA) combinations show high sustained virologic response (SVR) rates in HIV/HCV-coinfected patients, which are often close to those observed in HCV-monoinfected patients. Most recommendations regarding treatment stem from trials with coinfected patients. However, data are lacking for some aspects of HCV-treatment in coinfection, so extrapolations must be made from data obtained predominately from monoinfected patients. HIV/H…

medicine.medical_specialtyHepatitis C virusImmunologyPopulationHuman immunodeficiency virus (HIV)HIV Infectionsmedicine.disease_causeAntiviral AgentsVirusLiver diseaseChronic hepatitisVirologyInternal medicinemedicineHumansHiv infected patientsDrug Interactionseducationeducation.field_of_studyOncology (nursing)business.industryvirus diseasesHematologyHepatitis C Chronicmedicine.diseasedigestive system diseasesTreatment OutcomeInfectious DiseasesOncologyImmunologyCoinfectionDrug Therapy CombinationbusinessCurrent Opinion in HIV and AIDS
researchProduct

Reply to: Renal impairment and anemia during triple therapy

2014

medicine.medical_specialtyHepatologyAnemiabusiness.industryMEDLINEAnemiaHepatitis CHepatitis C Chronicmedicine.diseaseGastroenterologyInternal medicinemedicineHumansbusiness
researchProduct

Quantification of fibrosis in chronic hepatitis C: Performance of Transient Elastography and Acoustic Radiation Force Impulse using Collagen Proporti…

2014

medicine.medical_specialtyHepatologyChronic hepatitisbusiness.industryFibrosisGastroenterologyMedicineRadiologyImpulse (physics)businessTransient elastographymedicine.diseaseAcoustic radiation forceDigestive and Liver Disease
researchProduct

Transient elastography vs. platelets or APRI score to assess fibrosis in chronic hepatitis C

2008

medicine.medical_specialtyHepatologyChronic hepatitisbusiness.industryFibrosisInternal medicineGastroenterologymedicinePlateletbusinessTransient elastographymedicine.diseaseGastroenterologyDigestive and Liver Disease
researchProduct

The Italian ENTAS cohort study: Entecavir effectiveness in naïve and treatment experienced patients with chronic hepatitis B

2015

medicine.medical_specialtyHepatologyChronic hepatitisbusiness.industryInternal medicineGastroenterologyMedicineEntecavirbusinessTreatment experiencedmedicine.drugCohort studyDigestive and Liver Disease
researchProduct

Entecavir effectiveness in naïve and NUC experienced patients: Interim analysis of the ENTAS cohort study of patients with chronic hepatitis B

2014

medicine.medical_specialtyHepatologyChronic hepatitisbusiness.industryInternal medicineGastroenterologymedicineEntecavirInterim analysisbusinessmedicine.drugCohort studyDigestive and Liver Disease
researchProduct

Error factors for transient elastography in chronic hepatitis C

2008

medicine.medical_specialtyHepatologyChronic hepatitisbusiness.industryInternal medicineGastroenterologymedicineTransient elastographybusinessGastroenterologyDigestive and Liver Disease
researchProduct

PNPLA3 rs738409 C>G SNP is associated with histological features of NASH in genotype 1 chronic hepatitis C patients

2014

medicine.medical_specialtyHepatologyChronic hepatitisbusiness.industryInternal medicineGenotypeGastroenterologymedicineSNPbusinessGastroenterologyDigestive and Liver Disease
researchProduct

Retrospective, observational, multicentre study on the Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combi…

2009

medicine.medical_specialtyHepatologyCombination therapybusiness.industryRibavirinGastroenterologyItalian populationGastroenterologySurgerychemistry.chemical_compoundChronic hepatitischemistryInternal medicinemedicineObservational studybusinessNadir (topography)Digestive and Liver Disease
researchProduct